> How have we come to a point where we are arguing that a DEA schedule 1 drug (i.e., no accepted medical use) may be among the most promising lead therapies for psychiatric disease and a powerful probe of important brain functions?
I’ll make the observation that if recreational drugs weren’t doing interesting things to the brain, people wouldn’t use them, but psychedelics in particular do near miraculous seeming things with reproducibility that prescription drug companies would kill for in a candidate for a commercial drug.
I’ll make the observation that if recreational drugs weren’t doing interesting things to the brain, people wouldn’t use them, but psychedelics in particular do near miraculous seeming things with reproducibility that prescription drug companies would kill for in a candidate for a commercial drug.